We would like to introduce to you to Prof Kieran Harvey, the newest member of the Phenomics Australia’s Scientific Leaders team. Kieran will lead the Australian Drosophila Transgenic Facility, a new addition to Phenomics Australia In vivo Genome Engineering and Disease Modelling service.
Professor Kieran Harvey holds dual appointments at the Peter MacCallum Cancer Centre, where he leads the Organogenesis and Cancer Program, and Monash University, where he runs a laboratory in the Department of Anatomy and Developmental Biology.
Kieran’s team studies organ size control during development, using Drosophila, and how signalling pathways that control organ size are deregulated in human cancer. In particular, his group focuses on the Hippo pathway, which he helped to discover in the early 2000’s.
Kieran performed Doctoral studies with Prof. Sharad Kumar (University of Adelaide) and postdoctoral studies with Prof. Iswar Hariharan (Massachusetts General Hospital/Harvard Medical Center and University of California, Berkeley). He holds an NHMRC Investigator grant and was awarded the Gottschalk Medal by the Australian Academy of Science in 2014, for outstanding research in the medical sciences. He is the current president of the Australia and New Zealand Society for Cell and Developmental Biology.
“ Phenomics Australia provides essential support to Australian researchers by offering access to a broad range of cutting-edge technologies and expertise. These essential facilities drive innovation and allow Australian researchers to compete internationally. The establishment of the Australian Transgenic Drosophila Facility will allow any Australian scientist or clinician to embrace the power of Drosophila genetics to address their research questions”.